Загрузка...
Targeted Therapies for Hepatocellular Carcinoma
Unlike most solid tumors, incidence and mortality of hepatocellular carcinoma (HCC) have increased in the US and Europe in the last decade. Most patients are diagnosed at advanced stages, so there is an urgent need for new systemic therapies. Sorafenib, a tyrosine kinase inhibitor (TKI), has demonst...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3682501/ https://ncbi.nlm.nih.gov/pubmed/21406195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2011.03.006 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|